- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02980900
The Effect of Protein Ingestion on the Recovery of Skeletal Muscle Function Following Eccentric Exercise. (SPADE)
October 11, 2018 updated by: University of Exeter
The present study will assess the effect of the type and timing of protein ingestion 6 days prior to, and 7 days following eccentric exercise on the time course of 1) the recovery of muscle function, 2) the recovery of perceived muscle soreness, 3) muscle metabolism.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Devon
-
Exeter, Devon, United Kingdom, EX1 2LU
- Sport and Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women who are generally healthy and recreationally active
Exclusion Criteria:
- Active cardiovascular disease or hypertension
- Diagnosed metabolic impairment
- Use of nutritional supplements
- Use of anti-inflammatory medications
- Habitual dietary protein intake of <0.8g/kg/day
- Musculoskeletal disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo supplement
Post exercise placebo supplement Pre bed placebo supplement
|
Participants will ingest an isocaloric placebo supplement after exercise.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
Participants will ingest an isocaloric placebo supplement before bed.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
|
|
Active Comparator: Post exercise supplement
Post exercise protein-polyphenol supplement Pre bed placebo supplement
|
Participants will ingest an isocaloric placebo supplement before bed.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
Participants will ingest a post exercise protein-polyphenol supplement.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
|
|
Active Comparator: Pre bed supplement
Post exercise placebo supplement Pre bed protein-polyphenol supplement
|
Participants will ingest an isocaloric placebo supplement after exercise.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
Participants will ingest a protein-polyphenol supplement before bed.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
|
|
Active Comparator: Post exercise + pre bed supplement
Post exercise protein-polyphenol supplement Pre bed protein-polyphenol supplement
|
Participants will ingest a post exercise protein-polyphenol supplement.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
Participants will ingest a protein-polyphenol supplement before bed.
This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Isokinetic force production of the knee extensor muscles
Time Frame: 14 days
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Muscle protein synthesis
Time Frame: 14 days
|
14 days
|
|
Thigh volume
Time Frame: 14 days
|
14 days
|
|
Perceived muscle soreness
Time Frame: 14 days
|
14 days
|
|
Isometric force production of the knee extensor muscles
Time Frame: 14 days
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
August 1, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
November 30, 2016
First Submitted That Met QC Criteria
November 30, 2016
First Posted (Estimate)
December 2, 2016
Study Record Updates
Last Update Posted (Actual)
October 16, 2018
Last Update Submitted That Met QC Criteria
October 11, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 181739
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.